ArticleEuropean journal of neurology2024

Real-life effectiveness 1 year after switching to avalglucosidase alfa in late-onset Pompe disease patients worsening on alglucosidase alfa therapy: A French cohort study.

Céline Tard et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.